Zacks Investment Research
04 Sept 2026, 15:53 UTC · 7w ago
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
Impact · against what's priced in
HealthEquity shows strong operational momentum through increased EBITDA guidance and successful AI implementation that is lowering service costs. While cybersecurity remains a tail risk, the combination of guidance raises and asset growth suggests upside potential.
- HQY+0.40
No priced-in read yet
- In context
The company raised its fiscal 2027 adjusted EBITDA guidance to $628-$636 million and demonstrated margin expansion via AI, which now resolves 85% of routine chat inquiries.
Read from the article alone
Top 1 mover · tap to explore
